InVera Medical

Indonesia
Tangkanpulit, West Nusa Tenggara, Indonesia

Company profile

InVera Medical company profile

Venari Medical’s mission focus is on the innovation of unparalleled safe, effective, patient-centered medical devices that improve quality of life for those with debilitating vascular disease. Venari Medical are developing BioVena™ - a more effective, less invasive, and faster treatment for all venous disease patients. It is uniquely positioned to disrupt current treatment practices which have seen only medium level innovation in the past decade. The team is based at Ireland's medtech cluster in Galway. Only 1.3 million of the 120 million people in the US & EU who suffer from venous disease currently receive endovenous treatment each year. 3 million venous ulcer patients are completely unserved, using ineffective compression bandaging. Venari Medical offers an unrivaled lower risk and unparalleled effective non-thermal treatment which will allow more patients who suffer from Venous Disease to access effective treatment. The indication for the use of superficial venous ablation is also set to widen to treat venous ulcers that currently incur annual costs of $33Bn to insurers in the US & EU. The Venari Medical technology can be used as a safe and effective treatment for the whole spectrum of Venous Disease from varicose veins to active venous ulcers.

Business identity

Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2018-01-01, Year

Headquarters

Country code
ID
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
3
Total equity funding
$5.3M
Last funding
Grant / $2.7M / 2022-03-23
Last equity funding
Seed / $5.3M
Investors
5
Lead investors
2
Founders
1
Articles
10

Founders and investors

Founders

Stephen Cox

Lead investors

European Innovation CouncilNipro Corporation

Investors

Enterprise IrelandEuropean Innovation CouncilMedTech InnovatorNipro CorporationWestern Development Commission